Anthony Ravussin

Anthony Ravussin has held various positions in research and project leadership. Starting in 2017, they worked as a Postdoctoral Research Fellow at Oslo University Hospital until February 2021. From February 2021 to October 2022, they were employed as a Research Scientist at the Norwegian Institute of Public Health. Currently, they work in a senior position as a Discovery Project Leader and Senior Scientist at Nykode Therapeutics, starting in October 2022.

Anthony Ravussin has a strong background in education, with a focus on immunology and related fields. Anthony began their academic journey at Louisiana State University, where they studied immunology from 2011 to 2013. During this time, they also pursued a Doctor of Philosophy (PhD) degree at the Pennington Biomedical Research Center, specializing in immune-metabolic interactions.

After completing their studies at Pennington, Ravussin continued their research in immunology at Yale University from 2013 to 2016. There, they earned a PhD in Immunology and further developed their expertise in the field.

In 2022, Ravussin sought to expand their knowledge by pursuing a program in Vaccinology with a focus on clinical vaccine development and biomanufacturing. Anthony enrolled in the Department for Continuing Education at the University of Oxford for this purpose.

Overall, Anthony Ravussin's education history demonstrates a strong commitment to the study of immunology and related disciplines, showcasing their dedication to gaining expertise in these areas.